In a groundbreaking move aimed at improving mental health treatment options, Trump signed a series of executive orders to expedite the review and access of psychedelic drugs, including LSD, psilocybin, and ibogaine. Joined by podcaster Joe Rogan, who has been vocal about the benefits of psychedelics, Trump highlighted the significance of these substances in treating conditions such as PTSD, particularly for veterans. The recent executive orders direct the FDA to fast-track research and simplify restrictions surrounding these breakthrough therapies, paving the way for more comprehensive studies and eventual treatments. The White House has stated this initiative aims to address the growing demand for effective solutions in mental health care amid the ongoing opioid crisis.